近距離放射治療市場規模、佔有率、成長分析，按產品類型、按技術、按最終用戶、按應用、按地區 - 行業預測，2025 年至 2032 年

近距離放射治療市場規模預計在 2023 年達到 8 億美元，並從 2024 年的 8.7 億美元成長到 2032 年的 16.4 億美元，在預測期內（2025-2032 年）的複合年成長率為 8.3%。

由於癌症發病率的上升和技術的不斷進步，全球近距離放射治療市場預計將顯著成長。近距離放射治療透過導管將放射性物質直接輸送到體內，從而實現有針對性的放射治療，因此對治療局部腫瘤非常有效。國際癌症研究機構（IARC）預測，到2030年，全球癌症病例數將從1,930萬增加到2,460萬，這意味著對近距離放射治療的需求正在增加。此治療方法多種多樣，從治癒性治療到安寧療護，再加上最近的技術進步提高了治療的精確度並最大限度地減少了對健康組織的損害，因此越來越受到醫生的採用。預計未來幾年美國市場將維持強勁的複合年成長率，反映出對放射治療的持續投資和興趣。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

近距離放射治療市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概況
• 種子
• 施用器和後荷機
• 電子近距離放射治療

近距離放射治療市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 高劑量率 (HDR)
• 低劑量率 (LDR)

近距離放射治療市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 專科門診
• 其他

近距離放射治療市場規模（按應用和複合年成長率） (2025-2032)

• 市場概況
• 婦科癌症
• 攝護腺癌
• 乳癌
• 其他

近距離放射治療市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Elekta（瑞典）
• 碧迪公司（美國）
• 埃克特和齊格勒（德國）
• Theragenics（美國）
• iCAD（美國）
• CIVCO 醫療解決方案（美國）
• Isoray Medical（美國）
• 最佳醫療國際公司 (美國)
• AngioDynamics（美國）
• Carl Zeiss Meditec（德國）
• Nordion（加拿大）
• Oncura (英國)
• Sensus Healthcare（美國）
• IBA（比利時）
• RaySearch 實驗室（瑞典）
• ViewRay（美國）

結論和建議

Brachytherapy Market size was valued at USD 0.8 billion in 2023 and is poised to grow from USD 0.87 billion in 2024 to USD 1.64 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global brachytherapy market is poised for significant growth, driven by the rising prevalence of cancer and continuous technological advancements. Brachytherapy delivers targeted radiation by placing radioactive materials directly inside the body through catheters, making it highly effective for treating localized tumors. With the International Agency for Research on Cancer (IARC) projecting a rise in global cancer incidences from 19.3 million to 24.6 million by 2030, the demand for brachytherapy is on the rise. Its versatility in treatment-ranging from curative to palliative care-combined with recent innovations that enhance precision and minimize damage to healthy tissues, has increased adoption rates among physicians. The U.S. market is particularly expected to sustain a robust CAGR in the coming years, reflecting continued investment and interest in radiation therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Brachytherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Brachytherapy Market Segments Analysis

Global Brachytherapy Market is segmented by Product Type, Technique, End User, Application and region. Based on Product Type, the market is segmented into Seeds, Applicators and Afterloaders and Electronic Brachytherapy. Based on Technique, the market is segmented into High Dose Rate (HDR) and Low Dose Rate (LDR). Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on Application, the market is segmented into Gynecological Cancer, Prostate Cancer,breast cancerand Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Brachytherapy Market

The brachytherapy market is experiencing significant growth driven by the rising preference for minimally invasive treatment options among patients. These procedures are favored for their associated benefits, such as fewer post-operative complications, shorter hospital stays, and expedited recovery times. Brachytherapy stands out as a viable minimally invasive alternative, often allowing for outpatient treatment in numerous cases. As more patients seek options that minimize their recovery period and overall discomfort, the demand for these innovative procedures continues to escalate, further propelling the advancement and expansion of the brachytherapy market.

Restraints in the Brachytherapy Market

The Brachytherapy market faces significant restraints due to the necessity of specialized equipment and infrastructure needed for effective treatment planning, radiation delivery, and ensuring patient safety. The initial investment required for purchasing and installing this equipment can be substantial, presenting a financial barrier for many healthcare facilities. This is particularly pronounced in resource-limited areas where budgets may already be stretched thin. As a result, the substantial upfront costs can hinder the widespread adoption of brachytherapy technologies, limiting access to treatment and impeding market growth in certain regions, despite the benefits and effectiveness of the therapy itself.

Market Trends of the Brachytherapy Market

The brachytherapy market is witnessing a significant upward trend driven by the growing preference for organ-preserving treatments across various cancer types, particularly prostate, breast, and cervical cancers. This targeted radiation therapy minimizes collateral damage to healthy tissues, enhancing organ function and significantly improving patients' quality of life. As healthcare shifts towards more minimally invasive approaches, the adoption of brachytherapy is increasing, reinforced by advancements in technology and techniques that further improve treatment efficacy and safety. This trend aligns with patients and providers prioritizing personalized care, thereby establishing brachytherapy as a crucial modality in contemporary oncology practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Brachytherapy Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Seeds
• Applicators and Afterloaders
• Electronic Brachytherapy

Global Brachytherapy Market Size by Technique & CAGR (2025-2032)

• Market Overview
• High Dose Rate (HDR)
• Low Dose Rate (LDR)

Global Brachytherapy Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Brachytherapy Market Size by Application & CAGR (2025-2032)

• Market Overview
• Gynecological Cancer
• Prostate Cancer
• Breast Cancer
• Others

Global Brachytherapy Market Size & CAGR (2025-2032)

• North America (Product Type, Technique, End User, Application)
  • US
  • Canada
• Europe (Product Type, Technique, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technique, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technique, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technique, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Elekta (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theragenics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIVCO Medical Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isoray Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Medical International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oncura (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensus Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViewRay (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations